WCN24-1921 NEPHROTIC SYNDROME SECONDARY AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS DUE TO PODOCYTE KANK-2 MUTATION

WCN24-1921 NEPHROTIC SYNDROME SECONDARY AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS DUE TO PODOCYTE KANK-2 MUTATION

Saved in:

Bibliographic Details
Main Authors:	Sandra Liliana Borda Galindo, Mariana Ursino, Oscar Chávez, Mauro Lampo, Matías Monkowski, Fernando Lombi, Romina Iriarte, Mariano Forrester, Hernán Trimarchi
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924011689
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-1780 A TEN-YEAR EXPERIENCE OF ATYPICAL HEMOLYTIC UREMIC SYNDROME: A MONOCENTRIC PROSPECTIVE EXPERIENCE
by: Mariana Ursino, et al.
Published: (2024-04-01)

WCN24-2592 GENETIC DIAGNOSIS OF CHRONIC KIDNEY DISEASE: A SINGLE-CENTER STUDY
by: EUGENIA FLORES, et al.
Published: (2024-04-01)

WCN24-2542 HEMODYNAMIC INESTABILITY IN DIALYSIS AS A PREDICTOR OF MORTALITY IN CRITICALLY ILL PATIENTS
by: Leonel Langellotti, et al.
Published: (2024-04-01)

WCN24-2582 EPIDEMIOLOGICAL PROFILE OF KDIGO STAGE III ACUTE KIDNEY INJURY WITH THE NEED FOR RENAL SUPPORT THERAPY IN THE INTENSIVE CARE UNIT: OUR EXPERIENCE
by: Leonel Langellotti, et al.
Published: (2024-04-01)

WCN24-1884 THROMBOTIC MICROANGIOPATHY, SYSTEMIC LUPUS ERYTHEMATOSUS, AND A VITAMIN B12 MUTATION: A CAUSE OF PRIMARY ATYPICAL HEMOLYTIC UREMIC SYNDROME?
by: Jose Heriberto Díaz Góngora, et al.
Published: (2024-04-01)

Is There a Role for Mammalian Target of Rapamycin Inhibition in Renal Failure due to Mesangioproliferative Nephrotic Syndrome?
by: Hernán Trimarchi, et al.
Published: (2012-01-01)

Mucin-1 Gene Mutation and the Kidney: The Link between Autosomal Dominant Tubulointerstitial Kidney Disease and Focal and Segmental Glomerulosclerosis
by: H. Trimarchi, et al.
Published: (2018-01-01)

Podocyte specific knockout of the natriuretic peptide clearance receptor is podocyte protective in focal segmental glomerulosclerosis.
by: Liming Wang, et al.
Published: (2025-01-01)

Assessment of podocyte detachment as a pivotal step in the development of focal segmental glomerulosclerosis
by: Ikbal Ahmed Abdo Elkholy, et al.
Published: (2024-11-01)

Advances in Focal Segmental Glomerulosclerosis Treatment From the Perspective of the Newest Mechanisms of Podocyte Injury
by: Zhu Y, et al.
Published: (2025-02-01)

Protective Role of the Podocyte IL-15 / STAT5 Pathway in Focal Segmental Glomerulosclerosis
by: Aïssata Niasse, et al.
Published: (2024-04-01)

Comparison and prognostic analysis of focal segmental glomerulosclerosis patients with or without nephrotic syndrome at onset
by: Liangliang Chen, et al.
Published: (2025-07-01)

WCN25-63 Refractory Nephrotic Syndrome in Focal and Segmental Glomerulosclerosis by PMM2 Genetic Variant
by: Jaime Arturo Dulce M, et al.
Published: (2025-02-01)

WCN24-2606 KIDNEY RE-BIOPSY IN ADULTS WITH IGA NEPHROPATHY
by: Leonel Langellotti, et al.
Published: (2024-04-01)

WCN25-3085 MOLECULAR ALTERATIONS OF PODOCYTES IN PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND IMMUNOGLOBULIN A NEPHROPATHY: AN EXPLORATORY STUDY
by: Natalia Semenova, et al.
Published: (2025-02-01)

WCN25-3115 MOLECULAR ALTERATIONS OF PODOCYTES IN PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND IMMUNOGLOBULIN A NEPHROPATHY: AN EXPLORATORY STUDY
by: Vladimir Dobronravov, et al.
Published: (2025-02-01)

Nephrotic Syndrome due to Focal Segmental Glomerulosclerosis Complicating Sjögren’s Syndrome: A Case Report and Literature Review
by: Shigekazu Kurihara, et al.
Published: (2019-01-01)

Steroid‐Induced Psychosis in a Child With Nephrotic Syndrome Secondary to Focal Segmental Glomerulosclerosis: A Case Report
by: Sushan Pokharel, et al.
Published: (2024-12-01)

WCN25-3905 TMEM30A downregulation initiate podocyte injury through reducing glycolysis in focal segmental glomerulosclerosis
by: LI GUISEN
Published: (2025-02-01)

Focal Segmental Glomerulosclerosis and Scheduled Pretransplant Plasmapheresis: A Timely Diagnosis of Nail-Patella Syndrome Avoided More Futile Immunosuppression
by: H. Trimarchi
Published: (2020-01-01)

Familial focal segmental glomerulosclerosis in infancy
by: A Bakkaloğlu, et al.
Published: (1988-01-01)

Focal segmental glomerulosclerosis (FSGS) in pregnancy: The case of a 27-year-old woman with nephrotic syndrome at 22 weeks of gestation
by: Lucy Wang, et al.
Published: (2024-11-01)

WCN25-2069 RENAL-LOSS HYPOKALEMIA COMPLICATING FOCAL SEGMENTAL GLOMERULOSCLEROSIS PRESENTING AS NEPHROTIC SYNDROME: A RARE CASE
by: Calvin Kurnia Mulyadi, et al.
Published: (2025-02-01)

Focal segmental glomerulosclerosis: current status of the problem
by: I. T. Murkamilov, et al.
Published: (2020-01-01)

The Novel Diagnostic Biomarkers for Focal Segmental Glomerulosclerosis
by: Mohsen Nafar, et al.
Published: (2014-01-01)

Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study
by: Howard Trachtman, et al.
Published: (2024-04-01)

Glomerular parietal epithelial expression of CD44 in minimal change nephrotic syndrome and primary focal segmental glomerulosclerosis: A clinico-pathological study
by: Nithin E Paul, et al.
Published: (2023-07-01)

Is the Prevalence of Focal and Segmental Glomerulosclerosis Increasing in the Province of Khuzestan?
by: Seyed Seifollah Beladi Mousavi, et al.
Published: (2012-05-01)

WCN24-1132 ACTION3 – Phase 3 study of DMX-200 for the treatment of focal segmental glomerulosclerosis (FSGS)
by: Jonathon Barratt, et al.
Published: (2024-04-01)

WCN25-907 CLINICAL CHARACTERISTICS IN CHILDREN WITH MONOGENIC AND NON-GENETIC STEROID-RESISTANT NEPHROTIC SYNDROME DUE TO FOCAL SEGMENTAL GLOMERULOSCLEROSIS TREATED WITH CALCINEURIN INHIBITORS
by: Larisa Prikhodina
Published: (2025-02-01)

Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis
by: Wee Leng Gan, et al.
Published: (2018-10-01)

Intravenous Rituximab in Severe Refractory Primary Focal Segmental Glomerulosclerosis
by: Wee Leng Gan, et al.
Published: (2018-10-01)

Podocyte Glucocorticoid Receptor Expression and Treatment Outcome in Idiopathic Nephrotic Syndrome
by: Bartholomeus T. van den Berge, et al.
Published: (2025-07-01)

Glomerulosclerosis is a prognostic risk factor in patients with membranous nephropathy and non-nephrotic proteinuria
by: Jing Sun, et al.
Published: (2023-12-01)

WCN24-1899 RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN KIDNEY TRANSPLANTATION
by: Adriana M. Lituma, et al.
Published: (2024-04-01)

Antinephrin-Associated Primary Focal Segmental Glomerulosclerosis Successfully Treated With Plasmapheresis
by: Iain Bressendorff, et al.
Published: (2024-09-01)

Unraveling the Role of Complement in Focal Segmental Glomerulosclerosis Pathogenesis: Insights and Challenges
by: Alexandra Cambier, et al.
Published: (2024-06-01)

From Gene to Clinic: The Role of APOL1 in Focal Segmental Glomerulosclerosis
by: Charlotte Delrue, et al.
Published: (2025-02-01)

KANK1 regulates paclitaxel resistance in lung adenocarcinoma A549 cells
by: Junyi Pu, et al.
Published: (2020-01-01)

WCN24-2707 Focal and Segmental Glomerulosclerosis and Chronic Inflammatory Demyelinating Polyradiculoneuropathy: a Case Report
by: Katia Olga Teresa Hernández Torres, et al.
Published: (2024-04-01)